AI-Assisted Pathway Intelligence for U.S. Medical Devices

Initial launch focused on FDA medical device regulatory frameworks.

Request demo

What It Does

regul-AI-te supports regulatory professionals in structuring FDA strategy through AI-assisted contextual analysis.

The FDA Copilot assists with:

• Preliminary pathway identification
• 510(k), De Novo, and PMA contextual comparison
• Product classification reasoning
• Regulatory text interpretation
• Strategy structuring prior to formal submission preparation

It helps teams document reasoning and evaluate options clearly.

How It Works

Input Product Context

Provide device description, intended use, risk profile, and relevant technical context.

AI Contextual Analysis

The system evaluates applicable FDA regulatory frameworks, guidance documents, and classification patterns.

Structured Strategic Output

Receive pathway insights supported by structured reasoning and comparative regulatory analysis.

Designed for iterative refinement and human oversight.

Strategic Alignment

Regulatory pathway decisions directly influence:

• Clinical strategy
• Testing and validation requirements
• Timeline projections
• Resource allocation
• Market entry sequencing

regul-AI-te structures regulatory pathway analysis so strategic decisions are aligned with broader product development and commercialization plans.

It supports clarity before costly commitments are made.

Scope & Limitations

regul-AI-te does not:

• Replace regulatory professionals
• Submit documents to the FDA
• Provide legal advice
• Guarantee regulatory outcomes

It is an AI copilot designed to augment expertise and support structured regulatory reasoning.

ROADMAP Phase 1: FDA Medical Device Intelligence Phase 2: EU MDR Expansion Phase 3: Multi-Market Regulatory Intelligence

Connect With Us

This website uses cookies.

We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.